(RTTNews) - 
Merit Medical Systems, Inc. (MMSI:
) said that it will enter the microcatheter market with the introduction of the Merit Maestro Microcatheter in the United States during the first quarter of 2009. The company recently received clearance for the microcatheter from the Food and Drug Administration. Microcatheters are used to deliver various diagnostic, embolic and therapeutic materials to treat uterine Read the rest of this entry »

Think you know the facts about growing older? Think again.
Myth: Dementia is an inevitable part of aging.
“Dementia should be seen as a modifiable health condition and, if it occurs, should be followed as a medical condition, not a normal part of aging,” said Patricia Harris, MD, a geriatrician and associate professor at Georgetown University Medical Center. In other words, if you or your loved one becomes forgetful, it could be related to medication, Read the rest of this entry »

(RTTNews) - 
Friday, Liberator Medical Holdings Inc. (LBMH.PK:
) reported first-quarter net revenues of $5.45 million, compared to $1.43 million in the same quarter. This represents an annual run rate of $21.8 million.
The company attributed this revenue growth to the success of its national advertising campaign, which continues to increase our recurring revenue stream by attracting customers with long-term Read the rest of this entry »

(RTTNews) - 
Tuesday, Titan Medical Inc. (TMD.V:
) reported a third-quarter net loss of $939.0 thousand, compared to a loss of $9.7 thousand in the same quarter last year.
R&D investments for the quarter increased to $442.3 thousand from $3.8 thousand in the comparable quarter last year.
Net loss for the nine-month period was $2.4 million, compared to a loss of $64.6 thousand in the prior year period. R&D investments Read the rest of this entry »

Merit Medical Systems issues FY09, CY10 guidance – Quick Facts
(RTTNews) - 
Merit Medical Systems Inc. (MMSI:
) Thursday reported that earnings for Merit’s existing business would be in the range of $0.84-$0.86 per share for the year ending December 31, 2009. When adjusted to include business from the Alveolus and Biosearch transactions, Merit’s management estimates earnings to be in the range of $0.77-$0.79 per Read the rest of this entry »

(RTTNews) - 
China Medical Technologies Inc.(CMED:
) announced that its second quarter net income was RMB117.7 million or US$17.3 million, up from RMB77.4 million in the year ago quarter. Net income for the quarter was RMB4.13 per ADS or US$0.61 per ADS, compared to RMB2.88 per ADS in the comp able quarter of last year.
Adjusted net income was RMB154.3 million or US$22.7 million, up from RMB105.1 million in the Read the rest of this entry »

Think you know the facts about growing older? Think again.
Myth: Dementia is an inevitable part of aging.
“Dementia should be seen as a modifiable health condition and, if it occurs, should be followed as a medical condition, not a normal part of aging,” said Patricia Harris, MD, a geriatrician and associate professor at Georgetown University Medical Center. In other words, if you or your loved one becomes forgetful, it could be related to medication, Read the rest of this entry »

Think you know the facts about growing older? Think again.
Myth: Dementia is an inevitable part of aging.
“Dementia should be seen as a modifiable health condition and, if it occurs, should be followed as a medical condition, not a normal part of aging,” said Patricia Harris, MD, a geriatrician and associate professor at Georgetown University Medical Center. In other words, if you or your loved one becomes forgetful, it could be related to medication, Read the rest of this entry »

(RTTNews) - 
Tuesday, Globus Medical, Inc., a privately held spinal implant manufacturer, said that it appointed Wendy DiCicco, as Chief Financial Officer. For the last ten years, DiCicco was the CFO for Kensey Nash Corp. (KNSY:
), a medical device company.
DiCicco joined Kensey Nash in 1996 as corporate controller and became CFO in 1998. Prior to joining Kensey Nash, DiCicco was an Accounting and Audit Manager Read the rest of this entry »

(RTTNews) - 
Monday, Syneron Medical Ltd. (ELOS:
) announced its preliminary results for the third quarter. The company expects to report third-quarter net profit in the range of $3.4 million-$3.7 million or $0.11-$0.13 per share.
On average, five analysts polled by First Call/Thomson Financial currently expect the company to earn $0.27 per share for the third quarter.
Revenue for the quarter is expected in the Read the rest of this entry »